首页> 外文OA文献 >Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis
【2h】

Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis

机译:DNa错配修复基因位点的微卫星不稳定性和杂合性缺失发生在肝癌发生过程中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA mismatch repair is an important mechanism involved in maintaining the fidelity of genomic DNA. Defective DNA mismatch repair is implicated in a variety of gastrointestinal and other tumors; however, its role in hepatocellular carcinoma (HCC) has not been assessed. Formalin-fixed, paraffin-embedded archival pathology tissues from 46 primary liver tumors were studied by microdissection and microsatellite analysis of extracted DNA to assess the degree of microsatellite instability, a marker of defective mismatch repair, and to determine the extent and timing of allelic loss of two DNA mismatch repair genes, human Mut S homologue-2 (hMSH2) and human Mut L homologue-1 (hMLH1), and the tumor suppressor genes adenomatous polyposis coli gene (APC), p53, and DPC4. Microsatellite instability was detected in 16 of the tumors (34.8%). Loss of heterozygosity at microsatellites linked to the DNA mismatch repair genes, hMSH2 and/or hMLH1, was found in 9 cases (19.6%), usually in association with microsatellite instability. Importantly, the pattern of allelic loss was uniform in 8 of these 9 tumors, suggesting that clonal loss had occurred. Moreover, loss at these loci also occurred in nonmalignant tissue adjacent to 4 of these tumors, where it was associated with marked allelic heterogeneity. There was relatively infrequent loss of APC, p53, or DPC4 loci that appeared unrelated to loss of hMSH2 or hMLH1 gene loci. Loss of heterozygosity at hMSH2 and/or hMLH1 gene loci, and the associated microsatellite instability in premalignant hepatic tissues suggests a possible causal role in hepatic carcinogenesis in a subset of hepatomas.
机译:DNA错配修复是维持基因组DNA保真度的重要机制。缺陷DNA错配修复与多种胃肠道和其他肿瘤有关。但是,尚未评估其在肝细胞癌(HCC)中的作用。通过显微解剖和提取的DNA的微卫星分析研究了来自46种原发性肝肿瘤的福尔马林固定,石蜡包埋的档案病理组织,以评估微卫星不稳定性的程度(失配修复缺陷的标志物),并确定等位基因缺失的程度和时间两个DNA错配修复基因,人类Mut S同源物2(hMSH2)和人类Mut L同源物1(hMLH1),以及抑癌基因腺瘤性息肉病大肠杆菌基因(APC),p53和DPC4。在16个肿瘤(34.8%)中检测到微卫星不稳定性。与DNA失配修复基因hMSH2和/或hMLH1相关的微卫星杂合性的丧失被发现在9例(19.6%)中,通常与微卫星不稳定性有关。重要的是,这9个肿瘤中有8个的等位基因缺失模式是一致的,这表明已经发生了克隆缺失。此外,这些基因座的缺失也发生在与这些肿瘤中的4个相邻的非恶性组织中,这与明显的等位基因异质性有关。 APC,p53或DPC4基因座的丢失相对较少,与hMSH2或hMLH1基因基因座的丢失无关。 hMSH2和/或hMLH1基因位点的杂合性丧失以及相关的微卫星不稳定性在恶变前的肝组织中提示在子集性肝癌的肝癌发生中可能有因果作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号